If you’re actively trying to conceive, this is the point to pause any existing peptide research protocol and have a specific conversation with your fertility provider — not after a positive test, but now. Here’s the reasoning behind that recommendation.
Why Preconception Timing Matters
Early pregnancy detection often happens weeks after conception, meaning anything used around the time of conception has already had its window of exposure by the time a pregnancy is confirmed. This is why the recommendation is to address this before actively trying, not after.
GLP-1 Compounds Specifically
GLP-1 agonists are a specific flag in preconception planning conversations — both because of limited safety data in early pregnancy and because of documented interactions between GLP-1s and oral contraceptive absorption, which has its own set of planning implications if you’re transitioning off birth control while trying to conceive.
Hormone-Adjacent Peptides
Anything with direct hormonal or ovulation-related mechanisms, including Kisspeptin, warrants a specific conversation with your fertility provider about timing relative to your cycle and treatment plan, rather than continuing independently alongside a conception attempt.
The Blanket Recommendation
Absent compound-specific data showing safety during the preconception and early-pregnancy window — which is the case for nearly everything on this site — the conservative and responsible approach is to pause research use while actively trying to conceive, and to have your fertility provider read the entire list of what you’ve been researching.